• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于对3474个具有止血和血小板特征的基因进行表型分析的人和小鼠血小板转录组及蛋白质组。

Human and mouse platelet transcriptomes and proteomes for phenotyping 3474 genes with hemostatic and platelet traits.

作者信息

Huang Jingnan, Marini Federico, Solari Fiorella A, Swieringa Frauke, de Laat Bas, De Simone Ilaria, Grassi Luigi, Gui Xiang, Li Kunpeng, Middleton Elizabeth A, Morgan Neil V, Provenzale Isabella, Santos Carina, Schols Saskia, Westbury Sarah, Sickmann Albert, Rondina Matthew T, Ruf Wolfram, Frontini Mattia, Heemskerk Johan W M

机构信息

Department of Biochemistry, Maastricht University, Maastricht, The Netherlands.

Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.

出版信息

Blood Vessel Thromb Hemost. 2025 Mar 28;2(3):100068. doi: 10.1016/j.bvth.2025.100068. eCollection 2025 Aug.

DOI:10.1016/j.bvth.2025.100068
PMID:40765903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12320467/
Abstract

The hemostatic process relies on platelet and coagulation activation, with additional roles of red blood cells and the vessel wall. By systematic screening of databases for gene-linked information on hemostasis, we collected phenotypic profiles of 3474 orthologous human and mouse genes regarding bleeding, arterial thrombosis, thrombophilia, platelet traits, coagulation, and erythrocytes. Comparisons showed that defects in 252 mouse genes led to increased bleeding combined with platelet dysfunction or thrombocytopenia, in addition to 150 human orthologs that are registered for familial bleeding disorders, based on panel sequencing. Additionally, 139 mouse genes contributed to arterial thrombosis without bleeding phenotype. To further investigate the role of platelets in hemostasis, we integrated multiple genome-wide RNA-sequencing transcriptomes and proteomes from healthy subjects and C57BL/6 mice. This provided reference levels for 54 790 (54 247) transcripts and 6379 (4563) proteins in human (mouse) platelets. Orthologous transcripts in human and mouse platelets correlated with 0.75, whereas orthologous platelet proteins correlated with 0.87. Comparison with the phenotypic analysis revealed the following: (i) overall high qualitative similarity of human and mouse platelets regarding composition and function; (ii) presence of transcripts in platelets for most of the 3474 phenotyped genes; (iii) preponderance of syndromic platelet-expressed genes; and (iv) 20-40% overlap with genes from genome-wide association studies. For 42 mouse genes, among which receptors, signaling proteins, and transcription regulators (ASXL1, ERG, GATA2, MEIS1, NFE2, and TAL1), we confirmed novel links with human platelet function or count. This interspecies comparison can serve as a valuable resource for researchers and clinicians studying the genetics of blood-borne hemostasis and thrombosis.

摘要

止血过程依赖于血小板和凝血激活,红细胞和血管壁也发挥辅助作用。通过系统筛选数据库中与止血相关的基因信息,我们收集了3474个人类和小鼠直系同源基因在出血、动脉血栓形成、易栓症、血小板特征、凝血及红细胞方面的表型概况。比较结果显示,252个小鼠基因的缺陷除了导致出血增加外,还伴有血小板功能障碍或血小板减少,此外,基于全外显子组测序,有150个人类直系同源基因被登记为家族性出血性疾病。另外,139个小鼠基因导致动脉血栓形成但无出血表型。为进一步研究血小板在止血中的作用,我们整合了来自健康受试者和C57BL/6小鼠的多个全基因组RNA测序转录组和蛋白质组。这提供了人类(小鼠)血小板中54790(54247)个转录本和6379(4563)种蛋白质的参考水平。人类和小鼠血小板中的直系同源转录本相关性为0.75,而直系同源血小板蛋白相关性为0.87。与表型分析的比较显示:(i)人类和小鼠血小板在组成和功能方面总体上具有高度的质量相似性;(ii)3474个表型基因中的大多数在血小板中有转录本;(iii)综合征性血小板表达基因占优势;(iv)与全基因组关联研究中的基因有20 - 40%的重叠。对于42个小鼠基因,其中包括受体、信号蛋白和转录调节因子(ASXL1、ERG、GATA2、MEIS1、NFE2和TAL1),我们证实了它们与人类血小板功能或数量的新联系。这种种间比较可为研究血源性止血和血栓形成遗传学的研究人员和临床医生提供宝贵资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/09fff8304e50/BVTH_VTH-2024-000259-gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/f206cb2f5be2/BVTH_VTH-2024-000259-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/9a816d3a861e/BVTH_VTH-2024-000259-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/96128a5aea61/BVTH_VTH-2024-000259-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/5d5b168da36d/BVTH_VTH-2024-000259-gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/a4261330ab8c/BVTH_VTH-2024-000259-gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/569c2afa5944/BVTH_VTH-2024-000259-gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/1bf65bfccae5/BVTH_VTH-2024-000259-gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/09fff8304e50/BVTH_VTH-2024-000259-gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/f206cb2f5be2/BVTH_VTH-2024-000259-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/9a816d3a861e/BVTH_VTH-2024-000259-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/96128a5aea61/BVTH_VTH-2024-000259-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/5d5b168da36d/BVTH_VTH-2024-000259-gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/a4261330ab8c/BVTH_VTH-2024-000259-gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/569c2afa5944/BVTH_VTH-2024-000259-gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/1bf65bfccae5/BVTH_VTH-2024-000259-gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccf8/12320467/09fff8304e50/BVTH_VTH-2024-000259-gr7.jpg

相似文献

1
Human and mouse platelet transcriptomes and proteomes for phenotyping 3474 genes with hemostatic and platelet traits.用于对3474个具有止血和血小板特征的基因进行表型分析的人和小鼠血小板转录组及蛋白质组。
Blood Vessel Thromb Hemost. 2025 Mar 28;2(3):100068. doi: 10.1016/j.bvth.2025.100068. eCollection 2025 Aug.
2
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
3
Pathogen-reduced platelets for the prevention of bleeding.用于预防出血的去病原体血小板。
Cochrane Database Syst Rev. 2017 Jul 30;7(7):CD009072. doi: 10.1002/14651858.CD009072.pub3.
4
Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.在腰椎穿刺或硬膜外麻醉前使用血小板输注以预防血小板减少症患者的并发症。
Cochrane Database Syst Rev. 2018 Apr 30;4(4):CD011980. doi: 10.1002/14651858.CD011980.pub3.
5
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.
6
Pre-activated lyophilized platelets show non-inferior hemostatic effect compared with fresh platelets in rabbits with traumatic bleeding and shock.预激活冻干血小板在创伤性出血和休克兔中与新鲜血小板相比显示出非劣效性止血效果。
Platelets. 2025 Dec;36(1):2542767. doi: 10.1080/09537104.2025.2542767. Epub 2025 Aug 7.
7
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.抗纤溶药物(赖氨酸类似物)用于预防血液系统疾病患者出血。
Cochrane Database Syst Rev. 2013 Jul 29(7):CD009733. doi: 10.1002/14651858.CD009733.pub2.
8
Prophylactic platelet transfusions prior to surgery for people with a low platelet count.血小板计数低的患者在手术前进行预防性血小板输注。
Cochrane Database Syst Rev. 2018 Sep 17;9(9):CD012779. doi: 10.1002/14651858.CD012779.pub2.
9
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
10
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.比较不同血小板计数阈值,以指导预防性血小板输注的应用,从而预防血液系统疾病患者在骨髓抑制性化疗或干细胞移植后发生出血。
Cochrane Database Syst Rev. 2015 Nov 18;2015(11):CD010983. doi: 10.1002/14651858.CD010983.pub2.

本文引用的文献

1
A signature of platelet reactivity in CBC scattergrams reveals genetic predictors of thrombotic disease risk.CBC 散点图中的血小板反应性特征揭示了血栓性疾病风险的遗传预测因子。
Blood. 2023 Nov 30;142(22):1895-1908. doi: 10.1182/blood.2023021100.
2
Combining human platelet proteomes and transcriptomes: possibilities and challenges.整合人类血小板蛋白质组学和转录组学:可能性与挑战。
Platelets. 2023 Dec;34(1):2224454. doi: 10.1080/09537104.2023.2224454.
3
Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review.
先天性血友病 A 患者在接受预防性凝血因子 VIII 治疗时的出血事件:系统文献回顾。
Haemophilia. 2023 Jul;29(4):954-962. doi: 10.1111/hae.14803. Epub 2023 Jun 8.
4
New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF.关于 PF4 和 VWF 诱导和加速免疫相关性血栓形成的新观点。
Front Immunol. 2023 Feb 28;14:1098665. doi: 10.3389/fimmu.2023.1098665. eCollection 2023.
5
Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?低血管性血友病:一种病因不明的出血性疾病?
Hamostaseologie. 2023 Feb;43(1):44-51. doi: 10.1055/a-1980-8198. Epub 2023 Feb 20.
6
Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke.Glenzocimab:一种针对血小板糖蛋白 VI(GPVI)的潜在抗血小板药物,用于治疗急性缺血性脑卒中。
Stroke. 2022 Nov;53(11):3506-3513. doi: 10.1161/STROKEAHA.122.039790. Epub 2022 Sep 21.
7
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.干预重度月经过多;Cochrane 综述和网络荟萃分析概述。
Cochrane Database Syst Rev. 2022 May 31;5(5):CD013180. doi: 10.1002/14651858.CD013180.pub2.
8
Targeting platelet-derived CXCL12 impedes arterial thrombosis.靶向血小板衍生的 CXCL12 可抑制动脉血栓形成。
Blood. 2022 Apr 28;139(17):2691-2705. doi: 10.1182/blood.2020010140.
9
Emerging Technologies for Understanding Platelet Diversity.血小板多样性解析的新兴技术
Arterioscler Thromb Vasc Biol. 2022 May;42(5):540-552. doi: 10.1161/ATVBAHA.121.317092. Epub 2022 Mar 17.
10
Hemostatic phenotypes and genetic disorders.止血表型与遗传疾病。
Res Pract Thromb Haemost. 2021 Dec 16;5(8):e12637. doi: 10.1002/rth2.12637. eCollection 2021 Dec.